Paul Govern Archive — Page 38 of 54
-
December 1, 2016
Investigators explore new way to control mosquitoes
In a new study, Vanderbilt pharmacologist Jerod Denton, Ph.D., Ohio State entomologist Peter Piermarini, Ph.D., and colleagues report an experimental molecule that inhibits kidney function in mosquitoes and thus might provide a new way to control the deadliest animal on Earth. -
November 10, 2016
Grants enhance Tuberculosis Center’s global research efforts
Since July, investigators in the Vanderbilt Tuberculosis Center have been awarded research grants totaling $5 million. -
November 10, 2016
Program seeks to optimize appropriate use of antibiotics
Relying on a core team of physicians and pharmacists, the Vanderbilt Antimicrobial Stewardship Program (VASP) is seeking to ensure optimum use of antibiotics and other antimicrobial drugs at Vanderbilt University Medical Center (VUMC). -
October 27, 2016
Study tracks makeup of VUMC collaborative care teams
At Vanderbilt University Medical Center (VUMC) there are about 486 distinct operational units involved in inpatient care and evaluation. -
October 13, 2016
Antidepressants’ heart impact less than expected: study
A Vanderbilt University study published today in the Journal of Clinical Psychiatry may help patients prescribed higher doses of certain antidepressants feel better about attributed cardiac risks. -
October 7, 2016
Rheumatoid subtypes explored by PheWAS
A computer-based method pioneered at Vanderbilt is being used to compare subtypes of rheumatoid arthritis.